Latest Safety News

Centaurus Metals has secured a binding offtake deal with Glencore and attracted up to US$320 million in financing offers for its Jaguar Nickel Project, while advancing exploration and pilot testing at its Brazilian copper-gold and iron ore assets.

Beach Energy’s Q3 FY26 output rose 7% quarter-on-quarter, led by a 174% surge in Perth Basin production following Waitsia Gas Plant compressor commissioning. The company also secured new Queensland acreage and greenlit the Moomba Central Optimisation project, though weather disruptions trimmed Cooper Basin output and prompted a production guidance cut.

PYC Therapeutics fortified its balance sheet by $600 million and progressed key RNA therapeutic trials in Q1 2026, setting the stage for pivotal clinical data and regulatory submissions.

Central Petroleum lifted March quarter sales revenue to $11.3 million, driven by higher gas volumes and prices, while securing a significant multi-year gas supply deal with the Northern Territory Government that supports a 40% production capacity increase at Palm Valley.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Orthocell’s latest Remplir™ Real World Evidence study reveals an 89.7% treatment success rate across 78 nerve repair procedures, reinforcing its clinical strength and fueling US and European market growth plans.

dorsaVi is pivoting from wearable sensors to powering next-gen exoskeletons, leveraging its neuromorphic RRAM technology to tap a projected $2 billion market by 2033.

LTR Pharma has wrapped up recruitment for its SPONTAN Phase II pharmacokinetic study, with interim results expected soon to bolster FDA approval efforts. Meanwhile, US commercial talks for ROXUS advance cautiously under the FDA 503(a) personalised medicine pathway.

INOVIQ Limited is on track to complete its EXO-OC™ ovarian cancer screening study by mid-2026 and is accelerating its CAR-exosome therapy program, supported by a strong cash position of A$11.9 million.

King River Resources Ltd (ASX: KRR) has completed its acquisition of the Mindoolah Gold Project in Western Australia’s Murchison Province, unveiling a sophisticated exploration program leveraging digital twin technology and high-resolution geophysics to target substantial unmined high-grade gold mineralisation.

Aurelia Metals reported a strong March quarter with gold production rising to 13koz, upgraded FY26 guidance, and a new A$150 million financing deal that unlocks restricted cash and strengthens liquidity.

Greatland Resources delivered a record $260 million cash build in the March 2026 quarter, underpinned by 82,723 ounces of gold production at a $2,056/oz AISC and a 150% increase in Telfer's Mineral Resource Estimate to 8 million ounces gold.